Table 3. SARS-CoV-2–related mortality presented by month in a cohort of 9.1 million VA enrollees followed from February 2020 to February 2021.
Number of SARS-CoV-2–related deaths per month (and mortality per 100,000 persons per month) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Time period and number of VA enrollees at risk* | Entire period: February 2020 to February 2021 N = 9,127,673 |
February to March 2020 N = 9,127,673 |
April 2020 N = 9,090,196 |
May 2020 N = 9,053,082 |
June 2020 N = 9,022,051 |
July 2020 N = 8,990,833 |
August 2020 N = 8,948,674 |
September 2020 N = 8,913,864 |
October 2020 N = 8,881,573 |
November 2020 N = 8,844,680 |
December 2020 N = 8,804,424 |
January 2021 N = 8,744,388 |
February 2021 N = 8,671,916 |
All persons | 10,230 (9.3) |
83 (0.9) |
775 (8.5) |
631 (7.0) |
295 (3.3) |
627 (7.0) |
604 (6.7) |
375 (4.2) |
500 (5.6) |
1,165 (13.2) |
2,019 (22.8) |
2,172 (24.7) |
984 (11.3) |
Sex | |||||||||||||
Female | 208 (2.1) |
1 (0.1) |
14 (1.7) |
18 (2.2) |
7 (0.8) |
14 (1.7) |
15 (1.8) |
3 (0.4) |
11 (1.3) |
21 (2.6) |
42 (5.1) |
38 (4.7) |
24 (3.0) |
Male | 10,022 (10.1) |
82 (1.0) |
761 (9.2) |
613 (7.4) |
288 (3.5) |
613 (7.5) |
589 (7.2) |
372 (4.6) |
489 (6.1) |
1,144 (14.2) |
1,977 (24.7) |
2,134 (26.8) |
960 (12.1) |
Age (years) | |||||||||||||
18 to 24 | 0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
25 to 34 | 10 (0.1) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
2 (0.2) |
3 (0.4) |
5 (0.6) |
35 to 44 | 40 (0.3) |
0 (0.0) |
1 (0.1) |
3 (0.3) |
0 (0.0) |
5 (0.5) |
0 (0.0) |
1 (0.1) |
1 (0.1) |
1 (0.1) |
7 (0.7) |
13 (1.2) |
8 (0.8) |
45 to 54 | 153 (1.1) |
4 (0.3) |
16 (1.4) |
8 (0.7) |
4 (0.3) |
10 (0.9) |
12 (1.0) |
7 (0.6) |
10 (0.9) |
9 (0.8) |
34 (2.9) |
28 (2.4) |
11 (1.0) |
55 to 64 | 743 (4.1) |
11 (0.7) |
71 (4.7) |
36 (2.4) |
26 (1.7) |
59 (3.9) |
54 (3.6) |
21 (1.4) |
30 (2.0) |
68 (4.6) |
134 (9.0) |
160 (10.8) |
73 (5.0) |
65 to 74 | 3,354 (11.5) |
28 (1.1) |
272 (11.2) |
181 (7.5) |
86 (3.6) |
213 (8.9) |
206 (8.6) |
125 (5.2) |
165 (6.9) |
363 (15.3) |
662 (28.0) |
733 (31.2) |
320 (13.8) |
75 to 84 | 2,993 (19.8) |
20 (1.6) |
180 (14.4) |
157 (12.7) |
77 (6.2) |
171 (14.0) |
162 (13.3) |
113 (9.3) |
148 (12.3) |
366 (30.7) |
629 (52.8) |
656 (55.5) |
314 (26.9) |
≥85 | 2,937 (32.0) |
20 (2.6) |
235 (31.3) |
246 (33.4) |
102 (14.0) |
169 (23.6) |
170 (24.1) |
108 (15.5) |
146 (21.3) |
358 (52.9) |
551 (81.9) |
579 (86.9) |
253 (38.9) |
Race | |||||||||||||
White | 7,273 (10.3) |
34 (0.6) |
411 (7.0) |
406 (7.0) |
194 (3.3) |
409 (7.1) |
396 (6.9) |
271 (4.7) |
398 (7.0) |
913 (16.0) |
1,541 (27.1) |
1,561 (27.6) |
739 (13.2) |
Black | 1,935 (12.1) |
44 (3.3) |
309 (23.2) |
174 (13.1) |
74 (5.6) |
150 (11.4) |
138 (10.5) |
62 (4.7) |
59 (4.5) |
112 (8.6) |
277 (21.4) |
374 (29.0) |
162 (12.7) |
Asian | 65 (4.7) |
0 (0.0) |
3 (2.6) |
6 (5.2) |
2 (1.8) |
3 (2.6) |
8 (7.0) |
5 (4.4) |
1 (0.9) |
2 (1.8) |
15 (13.3) |
15 (13.3) |
5 (4.5) |
AI/AN | 125 (13.1) |
0 (0.0) |
6 (7.5) |
5 (6.3) |
4 (5.1) |
9 (11.4) |
8 (10.2) |
7 (9.0) |
9 (11.6) |
14 (18.0) |
27 (34.9) |
28 (36.4) |
8 (10.5) |
PI/NH | 87 (9.6) |
1 (1.3) |
4 (5.3) |
3 (4.0) |
3 (4.0) |
6 (8.1) |
4 (5.4) |
2 (2.7) |
3 (4.1) |
12 (16.4) |
20 (27.3) |
21 (28.9) |
8 (11.1) |
Missing/unknown/refused | 745 (3.8) |
4 (0.2) |
42 (2.6) |
37 (2.3) |
18 (1.1) |
50 (3.1) |
50 (3.1) |
28 (1.7) |
30 (1.9) |
112 (7.0) |
139 (8.7) |
173 (10.9) |
62 (3.9) |
Ethnicity | |||||||||||||
Non-Hispanic | 9,097 (10.5) |
75 (1.0) |
711 (9.9) |
577 (8.1) |
257 (3.6) |
516 (7.3) |
529 (7.5) |
341 (4.8) |
458 (6.5) |
1,053 (15.1) |
1,813 (26.1) |
1,904 (27.5) |
863 (12.6) |
Hispanic | 745 (10.9) |
8 (1.4) |
45 (7.9) |
32 (5.6) |
28 (4.9) |
89 (15.7) |
51 (9.0) |
21 (3.7) |
23 (4.1) |
75 (13.5) |
133 (23.9) |
158 (28.6) |
82 (15.0) |
Missing/unknown/refused | 388 (2.4) |
0 (0.0) |
19 (1.4) |
22 (1.6) |
10 (0.7) |
22 (1.6) |
24 (1.8) |
13 (1.0) |
19 (1.4) |
37 (2.8) |
73 (5.5) |
110 (8.3) |
39 (3.0) |
US Federal Region † | |||||||||||||
1 | 418 (8.7) |
2 (0.5) |
99 (24.8) |
86 (21.7) |
13 (3.3) |
6 (1.5) |
6 (1.5) |
3 (0.8) |
3 (0.8) |
24 (6.2) |
70 (18.1) |
65 (16.9) |
41 (10.7) |
2 | 704 (8.8) |
24 (3.6) |
237 (35.8) |
115 (17.5) |
16 (2.5) |
13 (2.0) |
4 (0.6) |
5 (0.8) |
9 (1.4) |
25 (3.9) |
82 (12.8) |
114 (17.9) |
60 (9.5) |
3 | 905 (7.9) |
3 (0.3) |
86 (9.0) |
72 (7.6) |
36 (3.8) |
29 (3.1) |
31 (3.3) |
19 (2.0) |
46 (4.9) |
80 (8.6) |
190 (20.4) |
213 (23.0) |
100 (10.9) |
4 | 2,385 (8.7) |
7 (0.3) |
77 (3.4) |
106 (4.7) |
85 (3.7) |
209 (9.2) |
237 (10.5) |
145 (6.5) |
116 (5.2) |
181 (8.1) |
362 (16.3) |
590 (26.7) |
270 (12.3) |
5 | 1,567 (9.8) |
17 (1.3) |
134 (10.2) |
113 (8.6) |
41 (3.1) |
34 (2.6) |
56 (4.3) |
35 (2.7) |
78 (6.0) |
316 (24.6) |
387 (30.2) |
236 (18.6) |
120 (9.5) |
6 | 1,567 (10.9) |
20 (1.7) |
74 (6.2) |
48 (4.0) |
33 (2.8) |
179 (15.2) |
133 (11.3) |
53 (4.5) |
91 (7.8) |
212 (18.3) |
273 (23.6) |
306 (26.6) |
145 (12.7) |
7 | 710 (12.9) |
2 (0.4) |
16 (3.5) |
28 (6.2) |
9 (2.0) |
12 (2.7) |
35 (7.8) |
53 (11.8) |
67 (15.0) |
143 (32.2) |
170 (38.5) |
125 (28.6) |
50 (11.6) |
8 | 387 (8.6) |
2 (0.5) |
11 (2.9) |
24 (6.5) |
11 (3.0) |
8 (2.2) |
7 (1.9) |
19 (5.2) |
48 (13.1) |
83 (22.7) |
104 (28.6) |
51 (14.1) |
19 (5.3) |
9 | 1,340 (10.7) |
3 (0.3) |
33 (3.2) |
26 (2.5) |
46 (4.5) |
123 (12.0) |
76 (7.4) |
30 (2.9) |
28 (2.8) |
68 (6.7) |
325 (32.1) |
425 (42.2) |
157 (15.8) |
10 | 247 (4.9) |
3 (0.7) |
8 (1.9) |
13 (3.1) |
5 (1.2) |
14 (3.4) |
19 (4.6) |
13 (3.2) |
14 (3.4) |
33 (8.1) |
56 (13.7) |
47 (11.6) |
22 (5.4) |
Urban versus rural | |||||||||||||
Rural | 5,002 (9.3) |
20 (0.4) |
151 (3.4) |
171 (3.9) |
116 (2.6) |
263 (6.0) |
319 (7.3) |
226 (5.2) |
320 (7.3) |
707 (16.3) |
1,124 (26.0) |
1,104 (25.6) |
481 (11.3) |
Urban | 5,228 (9.4) |
63 (1.4) |
624 (13.4) |
460 (10.0) |
179 (3.9) |
364 (7.9) |
285 (6.2) |
149 (3.3) |
180 (4.0) |
458 (10.1) |
895 (19.9) |
1,068 (23.8) |
503 (11.3) |
BMI (kg/m2) | |||||||||||||
<18.5 (underweight) | 304 (39.2) |
3 (4.6) |
28 (44.4) |
28 (45.2) |
16 (26.3) |
19 (31.8) |
15 (25.5) |
10 (17.3) |
12 (21.0) |
32 (56.7) |
46 (82.0) |
66 (118.8) |
29 (53.2) |
18.5 to <25 (normal weight) | 2,660 (12.0) |
21 (1.1) |
222 (12.1) |
215 (11.8) |
83 (4.6) |
158 (8.8) |
158 (8.8) |
108 (6.1) |
108 (6.1) |
261 (14.8) |
503 (28.6) |
549 (31.4) |
274 (15.8) |
25 to <30 (overweight) | 3,244 (8.2) |
29 (0.9) |
254 (7.7) |
188 (5.7) |
82 (2.5) |
201 (6.1) |
175 (5.4) |
125 (3.9) |
160 (4.9) |
368 (11.4) |
636 (19.8) |
718 (22.4) |
308 (9.7) |
30 to <35 (obese I) | 2,262 (7.7) |
13 (0.5) |
140 (5.8) |
127 (5.2) |
64 (2.7) |
146 (6.1) |
125 (5.2) |
81 (3.4) |
117 (4.9) |
291 (12.2) |
466 (19.6) |
481 (20.4) |
211 (9.0) |
35 to <40 (obese II) | 1,091 (8.9) |
12 (1.2) |
78 (7.6) |
41 (4.0) |
30 (2.9) |
57 (5.6) |
92 (9.1) |
33 (3.3) |
54 (5.4) |
120 (12.0) |
236 (23.6) |
235 (23.6) |
103 (10.5) |
≥40 (obese III) | 669 (12.5) |
5 (1.1) |
53 (11.9) |
32 (7.2) |
20 (4.5) |
46 (10.4) |
39 (8.9) |
18 (4.1) |
49 (11.2) |
93 (21.4) |
132 (30.5) |
123 (28.6) |
59 (13.9) |
CCI | |||||||||||||
0 to 1 | 1,450 (2.0) |
9 (0.1) |
94 (1.6) |
98 (1.6) |
43 (0.7) |
88 (1.5) |
93 (1.5) |
61 (1.0) |
73 (1.2) |
176 (3.0) |
279 (4.7) |
308 (5.2) |
128 (2.2) |
2 to 3 | 2,156 (11.8) |
20 (1.3) |
157 (10.4) |
115 (7.6) |
50 (3.3) |
122 (8.2) |
127 (8.5) |
78 (5.3) |
125 (8.5) |
244 (16.7) |
470 (32.2) |
429 (29.6) |
219 (15.3) |
4 to 5 | 2,331 (25.3) |
11 (1.4) |
161 (21.1) |
131 (17.3) |
75 (10.0) |
138 (18.4) |
137 (18.4) |
88 (11.9) |
89 (12.1) |
284 (39.0) |
467 (64.3) |
512 (71.2) |
238 (33.6) |
≥6 | 4,293 (46.2) |
43 (5.6) |
363 (47.5) |
287 (38.0) |
127 (17.0) |
279 (37.7) |
247 (33.8) |
148 (20.5) |
213 (29.9) |
461 (65.3) |
803 (114.5) |
923 (133.3) |
399 (58.9) |
* VA enrollees at risk are those who are still alive at the beginning of each time period and had not been infected with SARS-CoV-2 more than 30 days before the beginning of the time period.
† Categorized according to the 10 Federal Regions drawn up by the Federal Emergency Management Agency: 1 (CT, MA, ME, NH, RI, and VT), 2 (NJ, NY, and PR), 3 (DC, DE, MD, PA, VA, and WV), 4 (AL, FL, GA, KY, MS, NC, SC, and TN), 5 (IL, IN, MI, MN, OH, and WI), 6 (AR, LA, NM, OK, and TX), 7 (IA, KS, MO, and NE), 8 (CO, MT, ND, SD, UT, and WY), 9 (AZ, CA, GU, HI, and NV), and 10 (AK, ID, OR, and WA).
AI/AN, American Indian/Alaska Native; CCI, Charlson comorbidity index; PI/NH, Pacific Islander/Native Hawaiian; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; VA, Veterans Affairs.